comparemela.com

Latest Breaking News On - China national healthcare security administration - Page 4 : comparemela.com

HUTCHMED Announces Continued Inclusion of ELUNATE® (fruquintinib) and SULANDA® (surufatinib) in the National Reimbursement Drug List in China at Current Terms

HUTCHMED Announces Continued Inclusion of ELUNATE® (fruquintinib) and SULANDA® (surufatinib) in the National Reimbursement Drug List in China at Current Terms
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Zai Lab Limited (ZLAB) Announces First Listing of VYVGART, Other Updates in China s National Reimbursement Drug List

Zai Lab Limited (ZLAB) Announces First Listing of VYVGART, Other Updates in China s National Reimbursement Drug List
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Paratek Pharmaceuticals Announces Inclusion of Oral NUZYRA® in China s National Reimbursement Drug List

BOSTON, Dec. 13, 2023 (GLOBE NEWSWIRE) Paratek Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of…

Paratek Pharmaceuticals Announces Inclusion of Oral NUZYRA® in China s National Reimbursement Drug List

Paratek Pharmaceuticals Announces Inclusion of Oral NUZYRA® in China s National Reimbursement Drug List
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.